Utama › Penyakit Hati Steatotik › Virginia › Richmond
Kajian klinikal Penyakit Hati Steatotik di Richmond, VA
12 kajian untuk Penyakit Hati Steatotik sedang mencari peserta di lokasi dalam dan sekitar Richmond (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Mengambil pesertaFasa 3
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Mengambil pesertaFasa 3
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Mengambil pesertaFasa 2
- Virginia Commonwealth University, Richmond
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Mengambil pesertaFasa 2
- Richmond Veterans Administration Medical Center, Richmond
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Mengambil pesertaFasa 3
- Richmond Veterans Affairs Medical Center (Richmond VA Medical Center), Richmond
- Virginia Commonwealth University (VCU) Medical Center, Richmond
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Mengambil pesertaFasa 3
- Akero Clinical Study Site, Richmond
- Akero Clinical Study Site, Richmond
- Akero Clinical Study Site, Richmond
- dan 1 lagi
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Mengambil pesertaFasa 2
- GI Alliance Richmond, Richmond
- GI Select Health Research, Richmond
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Mengambil pesertaFasa 2
- GSK Investigational Site, Richmond
- GSK Investigational Site, Richmond
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Mengambil pesertaFasa 2
- GSK Investigational Site, Richmond
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
Mengambil pesertaFasa 2
- Virginia Commonwealth University, Richmond
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Mengambil peserta
- Virginia Common wealth University, Richmond
Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
Mengambil pesertaKajian pemerhatian
- Virginia Commonwealth University, Richmond
Kajian Penyakit Hati Steatotik di bandar lain
- San Antonio, TX17 kajian
- New York City, NY16 kajian
- Miami, FL16 kajian
- San Diego, CA14 kajian
- Austin, TX13 kajian
- Houston, TX13 kajian
- Tucson, AZ10 kajian
- Chandler, AZ10 kajian
- Hialeah, FL9 kajian
- Dallas, TX9 kajian
- Orlando, FL9 kajian
- St. Louis, MO9 kajian
Kajian lain di Richmond
- Kanser Payudara26 kajian
- Kanser Paru-paru Bukan Sel Kecil25 kajian
- Kanser Prostat19 kajian
- Kegagalan Jantung16 kajian
- Kanser Paru-paru14 kajian
- Penyakit Kardiovaskular13 kajian
- Kanser Kolorektal13 kajian
- Leukemia Mieloid Akut12 kajian
- Kanser Metastatik12 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher12 kajian
- Melanoma11 kajian
- Obesiti11 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.